| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028923 Computer based iterative processes for generating synthetic compounds with desired physical, chemical and/or bioactive properties |
| 03/07/2002 | US20020028922 Chemically modified oligonucleotide for site-directed mutagenesis |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028772 Modulation of metabolism |
| 03/07/2002 | US20020028519 Preferential detection of particle in sample; obtain sample, expose to light source, detect scattered light with eye, visibily scattered light indicates preferential particles in sample |
| 03/07/2002 | US20020028508 Novel genes encoding proteins having prognostic, diagnostic, preventive , therapeutic and other uses |
| 03/07/2002 | US20020028503 Devices for molecular biological analysis and diagnostics including waveguides |
| 03/07/2002 | US20020028502 Device for sizing nucleic acids, proteins or peptide nucleic acids |
| 03/07/2002 | US20020028495 Deoxyribonuclease II beta proteins and cDNAs |
| 03/07/2002 | US20020028489 Automated process for isolating and amplifying a target nucleic acid sequence |
| 03/07/2002 | US20020028487 Polypeptide; for use in detection of cell cycle modulators |
| 03/07/2002 | US20020028485 Polypeptide; for use in diagnosis and treatment of cancer, lung, cardiovascular, inflammation, kidney, pain, psychological and nervous system disorders |
| 03/07/2002 | US20020028482 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of autoimune disease, arthritis, infections, myasthenia gravis, asthma and cancer |
| 03/07/2002 | US20020028479 Quantitative analysis in culture |
| 03/07/2002 | US20020028478 Process for examining membrane enclosed biocompartments |
| 03/07/2002 | US20020028477 Assay for kinases and phosphatases |
| 03/07/2002 | US20020028476 Method of determining thiopurine methyltransferase activity |
| 03/07/2002 | US20020028472 Detecting modulator of ubiquitination during mitosis; obtain modulator, incubate with sample, monitor sample for adjustment in ubiquitination |
| 03/07/2002 | US20020028468 Detecting an atom mimic; screen interface, detecting atom on interface, bind ligand, adjust atom, monitor nuclear magnetic resonance profile, detect ligand mimic binding |
| 03/07/2002 | US20020028462 Alpha-2-macroglobulin isotype diagnostic test for Alzheimer's disease |
| 03/07/2002 | US20020028461 Methods for analyzing protein binding events |
| 03/07/2002 | US20020028460 Comparing copies of genes in genome; extract nucleotide sequences, amplify sequences, label sequences, hybridize sequences to chromosomes, detect signal and count genes |
| 03/07/2002 | US20020028459 Two-step hybridization and capture of a polynucleotide |
| 03/07/2002 | US20020028458 Amplifying signal associated with preferential nucleotide sequences; obtain nucleotide sequences, label, ligate target nucleotide sequences and adaptor molecule, amplify, recover sequences |
| 03/07/2002 | US20020028455 Methods and reagents for assembling molecules on solid supports |
| 03/07/2002 | US20020028454 Modeling and mapping gene expression; prepare samples, detect and compare expression from preferential genes, generate map, analyze clusters on map for gene expression, generate models of gene activity |
| 03/07/2002 | US20020028452 Measuring amount of nucleotide sequences in sample; obtain sample, ampify nucleotide sequences, determine initial concentration of the nucleic acid in sample |
| 03/07/2002 | US20020028448 Evaluating modulators of transcription; obtain modulator, incubate with test protein, monitor modulators binding activity, monitor for adjustment in transcriptional activation and protein expression |
| 03/07/2002 | US20020028445 Determining toxic and mutagenic compounds; obtain sample, incubate with mutagen, incubate with immobilized cells, monitor cells for mutant phenotypes |
| 03/07/2002 | US20020028443 Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
| 03/07/2002 | US20020028439 Apparatus for the detection and measurement of viruses in liquid |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028435 Method of monitoring the effect of cathepsin s inhibitors |
| 03/07/2002 | US20020028433 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 03/07/2002 | US20020028431 Process, device and reagent for cell separation |
| 03/07/2002 | US20020028203 T cell inhibitory receptor compositions and uses thereof |
| 03/07/2002 | US20020028165 Reaction vessels |
| 03/07/2002 | US20020027072 Biosensors with porous chromatographic membranes |
| 03/07/2002 | DE10041809A1 Arrays immobilisierter Biomoleküle, deren Herstellung und Verwendung Arrays of immobilized biomolecules, their preparation and use |
| 03/07/2002 | DE10041238A1 Verfahren zur Identifizierung spezifisch spaltbarer peptide und Verwendung solcher Peptidsequenzen A method for identifying specific cleavable peptide and use of such peptide sequences |
| 03/07/2002 | DE10038900A1 Einfache Methode zum drug monitoring von GPIIb/IIIa-Rezeptor-Antagonisten Simple method for drug monitoring of GPIIb / IIIa receptor antagonists |
| 03/07/2002 | DE10036342A1 Verfahren zur Bestimmung räumlicher Abstände in Polymeren oder Komplexen von Polymeren mit Hilfe von Gemischen von Cross-Linker Molekülen A method for determining spatial distances in polymers or complexes of polymers using mixtures of cross-linker molecules |
| 03/07/2002 | CA2457162A1 Electroprocessed fibrin-based matrices and tissues |
| 03/07/2002 | CA2428305A1 Detection of cyp3a4 and cyp2c9 polymorphisms |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421221A1 Statistical modeling to analyze large data arrays |
| 03/07/2002 | CA2421102A1 Nested methylation-specific polymerase chain reaction cancer detection method |
| 03/07/2002 | CA2421078A1 Method for determining alleles |
| 03/07/2002 | CA2420877A1 Isomaltulose synthase |
| 03/07/2002 | CA2420867A1 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | CA2420855A1 Improvements in and relating to marking using dna |
| 03/07/2002 | CA2420845A1 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 03/07/2002 | CA2420840A1 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420696A1 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof |
| 03/07/2002 | CA2420659A1 Genes expressed in the cell cycle |
| 03/07/2002 | CA2420657A1 Gene discovery using microarrays |
| 03/07/2002 | CA2420593A1 Tumor necrosis factor receptors 6.alpha. and 6.beta. |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420567A1 Mass spectrometric analysis of biopolymers |
| 03/07/2002 | CA2420322A1 Detection of cyp2d6 polymorphisms |
| 03/07/2002 | CA2420277A1 Antibodies specific for methylated lysines in histones |
| 03/07/2002 | CA2420105A1 Human kinases |
| 03/07/2002 | CA2420096A1 Detection of cyp2c19 polymorphisms |
| 03/07/2002 | CA2419860A1 Method for screening highly active proteases and inhibitors |
| 03/07/2002 | CA2419613A1 Methods for reducing complexity of nucleic acid samples |
| 03/07/2002 | CA2419578A1 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/07/2002 | CA2419251A1 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | CA2419152A1 Methods of using agents that modulate bone formation and inhibit adipogenesis |
| 03/07/2002 | CA2418502A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/07/2002 | CA2417233A1 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/07/2002 | CA2389310A1 Method of detecting gene |
| 03/06/2002 | EP1184665A1 Method for measuring protein kinase activity |
| 03/06/2002 | EP1184468A2 Method for sequencing using probe arrays |
| 03/06/2002 | EP1184467A2 Screening method for gene variation |
| 03/06/2002 | EP1184466A2 Target nucleic acid enrichment and amplification for array analysis |
| 03/06/2002 | EP1184465A2 Method for diagnosing polymorphisms in human MCT-1 and drugs related to such polymorphisms |
| 03/06/2002 | EP1184463A1 Method of detecting protein-protein interaction |
| 03/06/2002 | EP1184462A2 Identification of targets of antimicrobial compounds |
| 03/06/2002 | EP1184456A2 Haplotypes of the AGTR1 gene |
| 03/06/2002 | EP1184391A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1184390A2 Acetylcholine receptor subunits |
| 03/06/2002 | EP1184359A1 Generation of dynamic combinatorial libraries and assessment thereof by deconvolution |
| 03/06/2002 | EP1183541A1 Screening methods for altering circadian rhythm proteins |
| 03/06/2002 | EP1183540A1 Methods for predicting and/or diagnosing the risk of gastric cancer |
| 03/06/2002 | EP1183536A1 Fluorescence polarisation assays involving polyions |
| 03/06/2002 | EP1183535A2 Homogeneous tests for sequentially determining lipoprotein fractions |
| 03/06/2002 | EP1183534A2 Identification of novel mechanisms of drug resistance |
| 03/06/2002 | EP1183521A1 Nucleic acid-based detection |
| 03/06/2002 | EP1183516A1 Platform for chemical or biological analysis with microbalances, analysis device and method using same |
| 03/06/2002 | EP1183393A1 Pcr-based identification of eimeria species and strains |
| 03/06/2002 | EP1183392A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene |
| 03/06/2002 | EP1183391A2 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1 |
| 03/06/2002 | EP1183389A2 Adeno-associated virus-delivered ribozyme compositions and methods of use |
| 03/06/2002 | EP1183388A2 Shot-gun sequencing and amplification without cloning |
| 03/06/2002 | EP1183387A2 GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
| 03/06/2002 | EP1183382A2 Method for selecting improved vectors |
| 03/06/2002 | EP1183370A2 Human oxidoreductase proteins |